- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
iCAD third quarter revenues drop
Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period.
iCAD third quarter revenues drop
Third quarter revenues at computer-aided detection specialist iCAD dropped 37% to $7.1 million, but the company stayed in the black with net income of $113,000 compared with net income of $2.1 million in the year earlier period. For the first nine months total revenue declined 29% to $20.0 million from $28.2 million. Sales of digital CAD and MRI products led the decline with revenues falling to $12.7 million compared with $20.4 million over the two nine-month periods. Service and supply revenues actually increased to $2.8 million compared with $2.5 million. Film-based revenue of $4.6 million fell from $5.3 million. The company’s core digital mammography CAD business showed increased demand in the third quarter versus the second quarter, according to the company, as evidenced by the increased placements of full-field digital mammography systems posted in the Mammography Quality Standards Act data on the FDA website. Overall, revenues grew 24% compared with the second quarter of 2009. Ken Ferry, iCAD president and CEO, said he expects the sequential revenue growth to continue into the fourth quarter.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
